E1

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge

Merck KGaA’s Saturnus Bio bet signals a shift to genotype-driven cardiology, and a looming readiness gap for health systems

Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate

Cardiology has too many dashboards. The danger is forgetting the patient

Pregnancy complications demand long-term cardiovascular care

MENA’s cardiometabolic crisis is a stability issue

Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress

Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
